Last Posted: Jun 06, 2023
- Germline Genetic Testing After Cancer Diagnosis.
Allison W Kurian et al. JAMA 2023 - Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer.
Kelsey S Lau-Min et al. Journal of the National Comprehensive Cancer Network : JNCCN 2023 21(4) 351-358.e4 - Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
Subarnarekha Chatterji et al. The Lancet. Oncology 2023 2 (2) e74-e85 - Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
Clark Nina M et al. Annals of surgical oncology 2022 - A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.
Rutherford C L et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022 - Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis.
Davey Matthew G et al. Breast (Edinburgh, Scotland) 2022 6441-46 - Male Breast Cancer: From Molecular Genetics to Clinical Management.
Pensabene Matilde et al. Cancers 2022 14(8) - Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
Li Shuai et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 JCO2102112 - Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers.
Hamdi Yosr et al. Frontiers in oncology 2021 11674965 - Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.
Bayani Jane et al. NPJ breast cancer 2021 7(1) 98 - Men With Breast Cancer Need More Treatment Options and Access to Genetic Counseling
FDA, June 2021 - Germline pathogenic variants in the Ataxia Telangiectasia Mutated (ATM) gene are associated with high and moderate risks for multiple cancers.
Hall Michael J et al. Cancer prevention research (Philadelphia, Pa.) 2021 Jan - Breast Cancer Among Men
T Ellington, CDC Blog, October 2020 - Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
Calip Gregory S et al. Breast cancer research and treatment 2020 Sep - Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
Gaddam Sushma et al. Clinical breast cancer 2020 Jul - Common susceptibility loci for male breast cancer.
Maguire Sarah et al. Journal of the National Cancer Institute 2020 Aug - The molecular genetic make-up of male breast cancer.
Moelans Cathy B et al. Endocrine-related cancer 2019 26(10) 779-794 - Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study.
Bobbili Priyanka et al. Hereditary cancer in clinical practice 2020 1813 - Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.
Williams Austin D et al. Annals of surgical oncology 2020 May - Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe Rispah et al. Frontiers in genetics 2020 11170
More
Search Result Summary
- CDC Information (2)
- NIH Information (1)
- CDC Publications (0)
- Hot Topics Archive (35)
- Human Genome Epidemiologic Studies (135)
- GWAS Studies (2)
- Genomics Precision Health (72)
- Non-Genomics Precision Health (0)
- Pathogen Advanced Molecular Detection (0)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.